Market Signal Briefing

, /PRNewswire/ --

Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Alight, Inc. (NYSE: ALIT) between November 12, 2024 and February 18, 2026, both dates inclusive (the "Class Period"), of the important May 15, 2026 lead plaintiff deadline.

So what: If you purchased Alight common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

What to do next: To join the Alight class action, go to https://rosenlegal.com/submit-form/?case_id=54542 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 15, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

Details of the case: According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose facts concerning the true state of Alight's growth potential and financial stability; notably, that Alight was not truly equipped to execute on its claimed potential and could not maintain its promised dividend as a result. Rather, Alight would require significantly higher compensation and incentive expenses to achieve the projections put forth by management. Throughout the class period, defendants announced disappointing results, reduced projections, and multiple goodwill impairments all while remaining confident in their ability to execute, drive growth, and continue to provide a dividend to their shareholders. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Alight class action, go to https://rosenlegal.com/submit-form/?case_id=54542 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

     Laurence Rosen, Esq.
     Phillip Kim, Esq.
     The Rosen Law Firm, P.A.
     275 Madison Avenue, 40th Floor
     New York, NY 10016
     Tel: (212) 686-1060
     Toll Free: (866) 767-3653
     Fax: (212) 202-3827
     [email protected]
     www.rosenlegal.com

SOURCE THE ROSEN LAW FIRM, P. A.

The bulk of coverage towards the top gaining stock sectors over the past year has focused understandably on technology, which has made huge strides, with semiconductors exceeding +60%.

Repatha is the Only PCSK9 Inhibitor to Significantly Reduce the Risk of First CV Events in High-Risk Primary Prevention

VESALIUS-CV Subgroup Findings Reinforce Benefit of Earlier Initiation of Repatha in High-Risk Patients, with Median 44 mg/dL LDL-C Achieved

, /PRNewswire/ -- Amgen (NASDAQ:AMGN) announced today that Repatha® (evolocumab), when added to statins or other low-density lipoprotein cholesterol (LDL-C)-lowering treatments, reduced the risk of first major adverse cardiovascular (CV) events (MACE) in high-risk primary prevention patients without known significant atherosclerosis (buildup of plaque in the arteries) and with diabetes. The findings were presented in a late-breaking session at the American College of Cardiology (ACC) 75th Annual Scientific Session and simultaneously published in the Journal of the American Medical Association.

The results are from a new subgroup analysis of 3,655 patients at increased risk of CV events without known significant atherosclerosis (all of whom had diabetes) followed for a median of 4.8 years from the Phase 3 VESALIUS-CV clinical trial. Results showed Repatha reduced the risk of the composite primary endpoint of coronary heart disease (CHD) death, myocardial infarction or ischemic stroke (3‑P MACE) by 31% compared with placebo. Repatha also reduced the risk of a dual composite primary endpoint that included ischemia‑driven revascularization (4‑P MACE) by 31%. The median achieved LDL-C was 44 mg/dL at 96 weeks in the Repatha added to optimized lipid-lowering therapy arm compared to 105 mg/dL in the placebo plus optimized lipid-lowering therapy arm (548 patients in the subgroup were part of a lipid sub-study).

"The evidence is unequivocal: Intensive LDL-C lowering with Repatha significantly reduces the risk of major CV events for high-risk patients," said Jay Bradner, M.D., executive vice president of Research and Development at Amgen. "The new ACC/AHA Multisociety Guideline on the Management of Dyslipidemia reinforces the importance of earlier, more intensive lowering of LDL-C to prevent CV events. VESALIUS-CV builds on this, showing that in high-risk patients without prior heart attack or stroke, lowering LDL-C beyond what is typically achieved today can meaningfully reduce risk before ASCVD takes hold. These data also show the benefit of lowering LDL-C below 45 mg/dL with Repatha, a level that may not be achieved with statins or ezetimibe alone. Now is the time to treat earlier and help all appropriate patients reach lower LDL-C goals."

Across secondary endpoints, Repatha demonstrated consistent benefit, including the following composite endpoints: heart attack, ischemic stroke or any ischemia-driven revascularization; CHD death, heart attack or revascularization; CV death, heart attack or ischemic stroke. Among individual secondary endpoints, Repatha showed numerical reductions in the risk of heart attack by 31%, ischemia-driven revascularization by 34% and ischemic stroke by 33%. Repatha demonstrated numerical trends for reduced mortality rates, including CV death (32% relative risk reduction), CHD death (27% relative risk reduction) and all‑cause death (24% relative risk reduction).

"This analysis clearly demonstrates that the CV benefit of evolocumab in the VESALIUS-CV study includes those who had no known ASCVD, or significant plaque buildup in the arteries," said Nicholas Marston, M.D., M.P.H., assistant professor of medicine, member of the TIMI Study Group and cardiologist at Brigham and Women's Hospital and Harvard Medical School. "Lowering LDL-C earlier with more intensive therapy in high-risk primary prevention patients, before plaque becomes advanced, can prevent the clinical onset of heart disease. These findings confirm the substantial risk reduction that can be achieved by treating more proactively with evolocumab rather than waiting for the development of significant atherosclerosis or a CV event to then intensify lipid-lowering therapy."

For more information on Amgen abstracts and presentation times at the ACC 75th Annual Scientific Session, see below.

Evolocumab for the Reduction of First Major Cardiovascular Events in Patients without Significant Atherosclerosis: Results from VESALIUS-CV
LBS.105, Saturday, March 28 from 4:00 - 4:10 p.m. CST LDL-C Lowering and Associated Risk Reduction of Myocardial Infarction and Stroke-Related Hospitalizations in Patients with ASCVD and Diabetes
Abstract #1165-11, Monday, March 30 from 10:18 - 10:25 a.m. CST Cardiovascular disease (CVD) is the leading cause of death worldwide, and most CV events occur in people without a prior history of heart attack or stroke.1 High LDL-C is one of the most modifiable risk factors for heart attack and stroke, and prolonged exposure to elevated LDL‑C increases CV risk over time, making earlier and more intensive LDL‑C lowering critical to reducing the risk of a first CV event.2,3,4

Repatha was first approved in 2015 and has since been used by more than 8 million patients globally.5,6 In August 2025, the U.S. Food and Drug Administration broadened the approved use of Repatha to include adults at increased risk for major adverse CV events due to uncontrolled LDL-C.

About the VESALIUS-CV Trial
VESALIUS-CV is a Phase 3, double-blind, randomized, placebo-controlled, global clinical trial designed to evaluate the impact of LDL-C lowering with evolocumab on MACE in adults at high CV risk without prior heart attack or stroke. Results were published in the New England Journal of Medicine in November 2025. Repatha demonstrated a 25% relative reduction in the risk of a composite of coronary heart disease (CHD) death, heart attack or ischemic stroke (3-P MACE), and 19% reduction in a broader composite that also included any ischemia-driven arterial revascularization (4-P MACE). Repatha also reduced the risk of heart attack by 36%.

VESALIUS-CV enrolled more than 12,000 patients with known ASCVD or high-risk diabetes, who had no history of heart attack or stroke, an LDL-C ≥ 90 mg/dL, or non-high-density lipoprotein cholesterol (non-HDL-C) ≥ 120 mg/dL, or apolipoprotein B ≥ 80 mg/dL; and treated with highest tolerated dose of statin and/or ezetimibe. The median baseline LDL-C was 122 mg/dL (IQR, 104-149 mg/dL) on local lab testing. Participants were randomized to receive Repatha or placebo in addition to optimized lipid-lowering therapy and were followed for a median of approximately 4.6 years.

Amgen's Commitment to Cardiovascular Innovation
Cardiovascular disease (CVD) remains a major global health threat, linked to multiple interrelated risk factors like high LDL-C, Lp(a), obesity, diabetes and hypertension.7,8 These risks often coexist and require a comprehensive approach to prevention and care. Amgen is taking bold action, building on decades of leadership in CVD through LDL-C management to advance additional innovative, investigational treatments in the pipeline targeting common drivers of CVD. By combining scientific innovation with strategic partnerships to drive earlier testing, better care and broader access, Amgen's efforts reflect a sustained commitment to advancing both the science and the system of CV care.

About Repatha
Repatha is a human monoclonal antibody that inhibits proprotein convertase subtilisin/kexin type 9 (PCSK9). Repatha binds to PCSK9 and inhibits circulating PCSK9 from binding to the low-density lipoprotein (LDL) receptor (LDLR), preventing PCSK9-mediated LDLR degradation and permitting LDLR to recycle back to the liver cell surface. By inhibiting the binding of PCSK9 to LDLR, Repatha increases the number of LDLRs available to clear LDL from the blood, thereby lowering LDL-C levels.

Repatha is one of the most extensively studied PCSK9 inhibitors, with clinical and real-world evidence across diverse populations and CV risk profiles.8 The clinical benefits and safety of Repatha have been studied for 15 years in 51 clinical trials with over 57,000 patients.9 Repatha is the only PCSK9 inhibitor to demonstrate a significant reduction of cardiovascular events as both high-risk primary and secondary prevention. Repatha has been prescribed to over 8 million patients globally and is approved in 74 countries, including the U.S., Japan, Canada and in all 28 countries that are members of the European Union.9 Applications in other countries are pending.

INDICATIONS
 Repatha® is a PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitor indicated:

To reduce the risk of major adverse cardiovascular (CV) events (CV death, myocardial infarction, stroke, unstable angina requiring hospitalization, or coronary revascularization) in adults at increased risk for these events. As an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C) in: adults with hypercholesterolemia. adults and pediatric patients aged 10 years and older with heterozygous familial hypercholesterolemia (HeFH). adults and pediatric patients aged 10 years and older with homozygous familial hypercholesterolemia (HoFH). The safety and effectiveness of Repatha® have not been established in pediatric patients with HeFH or HoFH who are younger than 10 years old or in pediatric patients with other types of hypercholesterolemia. For full prescribing information, visit www.Repatha.com.

 IMPORTANT SAFETY INFORMATION   

Contraindication: Repatha® is contraindicated in patients with a history of a serious hypersensitivity reaction to evolocumab or any of the excipients in Repatha®. Serious hypersensitivity reactions including angioedema have occurred in patients treated with Repatha®. Hypersensitivity Reactions: Hypersensitivity reactions, including angioedema, have been reported in patients treated with Repatha®. If signs or symptoms of serious hypersensitivity reactions occur, discontinue treatment with Repatha®, treat according to the standard of care, and monitor until signs and symptoms resolve. Adverse Reactions in Adults with Primary Hypercholesterolemia: The most common adverse reactions (>5% of patients treated with Repatha® and more frequently than placebo) were: nasopharyngitis, upper respiratory tract infection, influenza, back pain, and injection site reactions.From a pool of the 52-week trial and seven 12-week trials: Local injection site reactions occurred in 3.2% and 3.0% of Repatha®-treated and placebo-treated patients, respectively. The most common injection site reactions were erythema, pain, and bruising. Hypersensitivity reactions occurred in 5.1% and 4.7% of Repatha®-treated and placebo-treated patients, respectively. The most common hypersensitivity reactions were rash (1.0% versus 0.5% for Repatha® and placebo, respectively), eczema (0.4% versus 0.2%), erythema (0.4% versus 0.2%), and urticaria (0.4% versus 0.1%).

Adverse Reactions in the FOURIER Cardiovascular Outcomes Trial: The most common adverse reactions (>5% of patients treated with Repatha® and more frequently than placebo) were: diabetes mellitus (8.8% Repatha®, 8.2% placebo), nasopharyngitis (7.8% Repatha®, 7.4% placebo), and upper respiratory tract infection (5.1% Repatha®, 4.8% placebo).Among the 16,676 patients without diabetes mellitus at baseline, the incidence of new-onset diabetes mellitus during the trial was 8.1% in patients treated with Repatha® compared with 7.7% in patients that received placebo.

Adverse Reactions in Pediatric Patients with HeFH: The most common adverse reactions (>5% of patients treated with Repatha® and more frequently than placebo) were: nasopharyngitis, headache, oropharyngeal pain, influenza, and upper respiratory tract infection. Adverse Reactions in Adults and Pediatric Patients with HoFH: In a 12-week study in 49 patients, the adverse reactions that occurred in at least two patients treated with Repatha® and more frequently than placebo were: upper respiratory tract infection, influenza, gastroenteritis, and nasopharyngitis. In an open-label extension study in 106 patients, including 14 pediatric patients, no new adverse reactions were observed. Immunogenicity: Repatha® is a human monoclonal antibody. As with all therapeutic proteins, there is potential for immunogenicity with Repatha®. Please see full Prescribing Information. 

About Amgen 
Amgen discovers, develops, manufactures and delivers innovative medicines to fight some of the world's toughest diseases. Harnessing the best of biology and technology, Amgen reaches millions of patients with its medicines.

More than 45 years ago, Amgen helped establish the biotechnology industry at its U.S. headquarters in Thousand Oaks, California, and it remains at the cutting edge of innovation, using technology and human genetic data to push beyond what is known today. Amgen is advancing a broad and deep pipeline and portfolio of medicines to treat cancer, heart disease, inflammatory conditions, rare diseases and obesity and obesity-related conditions.

Amgen has been consistently recognized for innovation and workplace culture, including honors from Fast Company and Forbes. Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average®, and it is also part of the Nasdaq-100 Index®, which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization.

For more information, visit Amgen.com and follow Amgen on X, LinkedIn, Instagram, YouTube, Facebook, TikTok and Threads.

Amgen Forward-Looking Statements
This news release contains forward-looking statements that are based on the current expectations and beliefs of Amgen. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements, including any statements on the outcome, benefits and synergies of collaborations, or potential collaborations, with any other company (including BeOne Medicines Ltd. or Kyowa Kirin Co., Ltd.), the performance of Otezla® (apremilast), our acquisitions of ChemoCentryx, Inc., Dark Blue Therapeutics, Ltd. or Horizon Therapeutics plc (including the prospective performance and outlook of Horizon's business, performance and opportunities, and any potential strategic benefits, synergies or opportunities expected as a result of such acquisition), as well as estimates of revenues, operating margins, capital expenditures, cash, other financial metrics, expected legal, arbitration, political, regulatory or clinical results or practices, customer and prescriber patterns or practices, reimbursement activities and outcomes, effects of pandemics or other widespread health problems on our business, outcomes, progress, and other such estimates and results. Forward-looking statements involve significant risks and uncertainties, including those discussed below and more fully described in the Securities and Exchange Commission reports filed by Amgen, including our most recent annual report on Form 10-K and any subsequent periodic reports on Form 10-Q and current reports on Form 8-K. Unless otherwise noted, Amgen is providing this information as of the date of this news release and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise.

No forward-looking statement can be guaranteed and actual results may differ materially from those we project. Discovery or identification of new product candidates or development of new indications for existing products cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate or development of a new indication for an existing product will be successful and become a commercial product. Further, preclinical results do not guarantee safe and effective performance of product candidates in humans. The complexity of the human body cannot be perfectly, or sometimes, even adequately modeled by computer or cell culture systems or animal models. The length of time that it takes for us to complete clinical trials and obtain regulatory approval for product marketing has in the past varied and we expect similar variability in the future. Even when clinical trials are successful, regulatory authorities may question the sufficiency for approval of the trial endpoints we have selected. We develop product candidates internally and through licensing collaborations, partnerships and joint ventures. Product candidates that are derived from relationships may be subject to disputes between the parties or may prove to be not as effective or as safe as we may have believed at the time of entering into such relationship. Also, we or others could identify safety, side effects or manufacturing problems with our products, including our devices, after they are on the market.

Our results may be affected by our ability to successfully market both new and existing products domestically and internationally, clinical and regulatory developments involving current and future products, sales growth of recently launched products, competition from other products including biosimilars, difficulties or delays in manufacturing our products and global economic conditions, including those resulting from geopolitical relations and government actions. In addition, sales of our products are affected by pricing pressure, political and public scrutiny and reimbursement policies imposed by third-party payers, including governments, private insurance plans and managed care providers and may be affected by regulatory, clinical and guideline developments and domestic and international trends toward managed care and healthcare cost containment. Furthermore, our research, testing, pricing, marketing and other operations are subject to extensive regulation by domestic and foreign government regulatory authorities. Our business may be impacted by government investigations, litigation and product liability claims. In addition, our business may be impacted by the adoption of new tax legislation or exposure to additional tax liabilities. Further, while we routinely obtain patents for our products and technology, the protection offered by our patents and patent applications may be challenged, invalidated or circumvented by our competitors, or we may fail to prevail in present and future intellectual property litigation. We perform a substantial amount of our commercial manufacturing activities at a few key facilities, including in Puerto Rico, and also depend on third parties for a portion of our manufacturing activities, and limits on supply may constrain sales of certain of our current products and product candidate development. An outbreak of disease or similar public health threat, and the public and governmental effort to mitigate against the spread of such disease, could have a significant adverse effect on the supply of materials for our manufacturing activities, the distribution of our products, the commercialization of our product candidates, and our clinical trial operations, and any such events may have a material adverse effect on our product development, product sales, business and results of operations. We rely on collaborations with third parties for the development of some of our product candidates and for the commercialization and sales of some of our commercial products. In addition, we compete with other companies with respect to many of our marketed products as well as for the discovery and development of new products. Further, some raw materials, medical devices and component parts for our products are supplied by sole third-party suppliers. Certain of our distributors, customers and payers have substantial purchasing leverage in their dealings with us. The discovery of significant problems with a product similar to one of our products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on our business and results of operations. Our efforts to collaborate with or acquire other companies, products or technology, and to integrate the operations of companies or to support the products or technology we have acquired, may not be successful, and may result in unanticipated costs, delays or failures to realize the benefits of the transactions. A breakdown, cyberattack or information security breach of our information technology systems could compromise the confidentiality, integrity and availability of our systems and our data. Our stock price is volatile and may be affected by a number of events. Our business and operations may be negatively affected by the failure, or perceived failure, of achieving our sustainability objectives. The effects of global climate change and related natural disasters could negatively affect our business and operations. Global economic conditions may magnify certain risks that affect our business. Our business performance could affect or limit the ability of our Board of Directors to declare a dividend or our ability to pay a dividend or repurchase our common stock. We may not be able to access the capital and credit markets on terms that are favorable to us, or at all.

CONTACT: Amgen, Thousand Oaks
Madison Howard, 773-636-4910 (media)
Elissa Snook, 609-251-1407 (media)
Casey Capparelli, 805-447-1746 (investors) 

REFERENCES

Martin SS, Aday AW, Allen NB, et al. American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Committee. 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association. Circulation. 2025151(8)le41–e660. https://doi.org/10.1161/CIR.0000000000001303 Jurin I, et al. Outcomes of patients with normal LDL-cholesterol at admission for acute coronary syndromes: lower is not always better. J Cardiovasc Dev Dis. 2024;11(4):120. https://doi.org/10.3390/jcdd11040120 Domanski MJ, Tian X, Wu CO, et al. Time course of LDL cholesterol exposure and cardiovascular disease event risk. J Am Coll Cardiol. 2024;76(13):1507-1516. Kalra DK, Ray KK, Bajaj A, et al.  Low-density lipoprotein cholesterol lowering and risk of major adverse cardiovascular events in primary prevention trials: A meta-analysis. J Clin Lipidol. 2026. Shapiro MD. Prolonged and Pronounced Low-Density Lipoprotein Cholesterol Lowering: The Gift That Keeps Giving. Circulation. 2022;146(15):1120-1122.  Rao SV, O'Donoghue ML, Ruel M, et al. 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2025;151(13):e771-e862. Vasan RS, Enserro DM, Xanthakis V, Beiser AS, Seshadri S. Temporal trends in the remaining lifetime risk of cardiovascular disease among middle-aged adults across 6 decades: the Framingham Study. Circulation. 2022:145(17):1324-1338. https://doi.org/10.1161/CIRCULATIONAHA.121.057889 Tsimikas S, Marcovina S. Ancestry, lipoprotein(a), and cardiovascular risk thresholds: JACC Review Topic of the Week. JACC. 2022;80(9):934-946. https://doi.org/10.1016/j.jacc.2022.06.019 MAC: REF-99099 Data on File. Amgen, 2025. SOURCE Amgen

Why Trust CoinGape

CoinGape has covered the cryptocurrency industry since 2017, aiming to provide informative insights to our readers. Our journal analysts bring years of experience in market analysis and blockchain technology to ensure factual accuracy and balanced reporting. By following our Editorial Policy, our writers verify every source, fact-check each story, rely on reputable sources, and attribute quotes and media correctly. We also follow a rigorous Review Methodology when evaluating exchanges and tools. From emerging blockchain projects and coin launches to industry events and technical developments, we cover all facets of the digital asset space with unwavering commitment to timely, relevant information.

The Morgan Stanley Bitcoin ETF (MSBT) will boast the lowest fees among the BTC ETFs, except Van Eck’s fund, which has a fee waiver, when it launches. Bloomberg analyst Eric Balchunas described the low fees as a smart move as the bank looks to rival BlackRock’s IBIT, which is the largest Bitcoin ETFs.

Morgan Stanley Bitcoin ETF To Have Lowest Fees Upon Launch In an X post, Bloomberg analyst Eric Balchunas drew attention to the fact that the bank plans to charge a management fee of 0.14% for its Bitcoin ETF. The ETF will boast the lowest fees among the BTFs upon launch, notably lower than Grayscale’s Mini Bitcoin Trust, which has a management fee of 0.15%.

As Balchunas noted, the 0.14% fee for the Morgan Stanley Bitcoin ETF will be 0.11% lower than BlackRock’s IBIT, which has a management fee of 0.25%. The Bloomberg analyst stated that this means that none of the bank’s advisors will feel conflicted about using the bank’s BTC ETF and that the fund could also attract outside assets with this low fee.

The analyst further described this as a smart move. He had earlier praised Morgan Stanley’s decision to file for a Bitcoin ETF, noting that it made sense, given that the Wall Street giant had about $8 trillion in advisory assets and had already approved clients’ allocations to Bitcoin funds.

As CoinGape reported, Morgan Stanley already filed an amended prospectus with the SEC, with key details such as the ticker and exchange. The Morgan Stanley Bitcoin ETF will trade on the NYSE Arca under the ticker ‘MSFT.’ Notably, this will be the first Bitcoin ETF issued by a bank.

Fund Likely To Launch In April Balchunas said that the Morgan Stanley Bitcoin ETF will probably launch in the next two weeks. The analyst previously pointed out that the BTC ETF already got an official listing from the NYSE, which typically means that a launch is imminent.

The ETF’s imminent launch comes at a time when the BTC ETFs are seeing mixed flows amid the Bitcoin price downtrend. Balchunas reiterated that this particular launch is “interesting” because it will be the first bank to put out a spot Bitcoin ETF, and that they happen to have 16,000 advisors managing $6 trillion in assets. “They are the ultimate gatekeepers of rich boomer money,” he added.

Commenting on the Morgan Stanley Bitcoin ETF fee, Bloomberg analyst James Seyffart described it as a “big move.” He also noted that the bank has filed for Ethereum and Solana ETFs and that this move may indicate that the fees on those funds are about to undercut the market as well.

Sentient [SENT] drops 14.3% to $0.01585 as volume surges 65% to $24.32 million at press time, reflecting aggressive sell-side activity despite rising market participation. 

Sellers continue to dominate order flow, pushing price lower despite increased liquidity entering the market. Volume expansion under declining price conditions usually signals that participants are exiting positions rather than accumulating. 

As a result, this structure shows clear sell-side control, where each attempt to stabilize gets absorbed quickly. The market reflects urgency from participants reducing exposure, which reinforces the ongoing SENT downside pressure.

SENT breakdown below support exposes SENT price has broken below the $0.01891 support level and continues to extend lower toward the $0.01106 demand zone. This breakdown confirms that previous consolidation has failed to hold, shifting structure into a continuation phase. 

Lower highs have remained intact across recent sessions, which reinforces bearish control over the trend. Attempts to reclaim the lost support have lacked follow-through, showing weak buyer commitment. 

As price trades below key levels, market structure reflects continuation rather than reversal. This positioning suggests that sellers continue to dictate direction as the asset searches for a stronger demand base.

At press time, RSI dropped to 29.06, pushing Sentient into oversold territory and confirming the intensity of recent selling pressure. This reading reflects persistent downside strength rather than a temporary pullback. 

While oversold conditions sometimes hint at short-term relief, the broader structure still aligns with continued weakness.

Source: TradingView Falling OI signals capital withdrawal Open Interest (OI) has declined 16.30% to $19.76 million, indicating that leveraged traders are closing positions rather than opening new ones. This drop reflects a clear reduction in market participation from derivatives traders, especially those previously positioned on the long side. 

As positions close, liquidity exits the market, which reduces the probability of immediate recovery. The decline in OI aligns closely with the price drop, confirming that traders are stepping away instead of defending positions. This behavior highlights a broader shift toward risk reduction across the market.

Source: CoinGlass Long liquidations dominate across exchanges Liquidation data shows that long positions have faced heavy losses, with approximately $51K in longs wiped out compared to just $96 in short liquidations. This imbalance reflects aggressive forced exits, particularly across major exchanges like Binance and OKX. 

When long positions get liquidated at this scale, they amplify downward pressure as positions close automatically. This cascade effect accelerates price declines and weakens bullish positioning further. 

The dominance of long liquidations confirms that traders who expected upside continuation have exited under pressure, leaving the market tilted toward sellers.

Source: CoinGlass Is SENT nearing stabilization or further downside? SENT continues to face sustained downside pressure as structure, liquidations, and capital outflows align against recovery. 

The breakdown below support, combined with the OI drop and dominant long liquidations, reflects a market still unwinding bullish exposure. Although RSI has entered oversold territory, current conditions do not support a stable rebound. 

SENT would likely continue drifting lower toward the $0.01106 zone before any meaningful stabilization attempt emerges.

Final Summary Sentient shows weakening structure as sellers maintain control and buyers fail to defend key levels effectively. Market positioning reflects reduced confidence, suggesting price would continue drifting lower before any meaningful stabilization emerges. 

TLDR: Chris Peikert joins Algorand Foundation as CSO, bringing deep expertise in post-quantum and lattice-based cryptography. Four protocol engineers from Algorand Technologies now support the Foundation’s growing technical infrastructure team. A mandatory Pre-ARC discussion phase will filter proposals before they advance to formal draft or finalization status. ARC Kit CLI is introduced as the standard tool to enforce formatting, rules, and transitions across all ARC submissions. Algorand Foundation has announced two major developments this week. The organization welcomed five new team members from Algorand Technologies.

At the same time, a structural update to the Algorand Request for Comments process was also revealed. These moves reflect the Foundation’s commitment to strengthening protocol engineering and ecosystem governance.

Together, they position Algorand Foundation as a more unified and accountable blockchain organization globally.

Algorand Foundation Strengthens Protocol Engineering with Key Hires Chris Peikert has joined Algorand Foundation as Chief Scientific Officer. He previously served as Head of Cryptography at Algorand Technologies.

Peikert is also the Arthur W. Burks Collegiate Professor of Computer Science at the University of Michigan. Additionally, he is a Fellow of the International Association for Cryptology Research. His expertise centers on lattice-based and post-quantum cryptography.

Peikert led Algorand’s post-quantum security implementations before this transition. He will continue that same work in his new role.

This move follows the unification of protocol and ecosystem operations under Algorand Foundation. The consolidation was designed to bring key technical leadership together under one structure.

John Jannotti also joined as Senior Vice President of Protocol Engineering. He will lead the Foundation’s Protocol Engineering team going forward.

Under his leadership, Pavel Zbitskiy and one additional team member took on roles as Principal Protocol Engineers. John Lee joined separately as Director of Protocol Infrastructure.

As Algorand shared on X, the five hires are described as “invaluable additions to the Algorand Foundation technical team.”

Five team members from Algorand Technologies have joined the @AlgoFoundation team.

Chris Peikert, professor of computer science at the University of Michigan and leading post-quantum cryptographer, has joined the Algorand Foundation as Chief Scientific Officer. Chris led… pic.twitter.com/1zat2H11Iw

— Algorand (@Algorand) March 27, 2026

Their work will support payments, asset tokenization, and decentralized financial infrastructure. The Foundation sees this expanded team as central to its mission of global financial empowerment through blockchain.

Algorand Foundation Introduces Reforms to the ARC Governance Process The Algorand Request for Comments process is also undergoing formal reform. Cusma, who is now managing the ARC repository, outlined the update on X.

He thanked outgoing maintainer Stéphane Barros for his contributions to the process. The reform aims to improve consistency, reduce fragmentation, and avoid premature ARC finalization.

One major change is a mandatory Pre-ARC discussion phase. Before any proposal becomes a formal draft, authors must establish a clear need and scope.

Overlap with existing ARCs must also be examined during this phase. This step is meant to filter out proposals that lack practical grounding.

Every ARC will now also require a named sponsor — either Algorand Foundation or an Algorand Ecosystem entity.

Machine-readable adoption tracking will be mandatory before an ARC advances from “Last Call” to “Final.” This ensures that only proposals with proven ecosystem usage reach final status.

A new tool called ARC Kit CLI will support the process going forward. It enforces formatting, rules, and state transitions for ARC authors.

Cusma plans to share full details at the next Algorand Developer Council meeting. The reforms are focused on making ARCs easier to maintain and more aligned with real-world adoption.

TLDR: Canton’s anti-ZK argument rests on a hidden assumption that no backup system exists to catch failures. Canton’s trust-only model has no cryptographic layer, leaving compromised keys to spread damage silently. Prividium deploys three independent defense layers, keeping any breach contained to a single institution’s chain. DAML faces the same maturity concerns Canton raises about ZK proofs, but with far fewer security eyes watching. Zero-knowledge proofs are at the center of a growing debate in institutional finance. Canton Network founders have argued that ZK proofs pose unacceptable risks for mission-critical financial systems.

They have raised this case with buyers and regulators, both publicly and privately. A public response from ZK researcher Alex challenges that argument directly.

The rebuttal compares the architectural approaches of Canton and Prividium.

Canton’s Risk Case and the Assumption It Rests On Canton’s argument against ZK proofs centers on their complexity. Bugs in such systems may go undetected because the underlying data stays private.

If a flaw spreads silently, it could create systemic risk across financial networks. The concern is genuine, but the logic that follows contains a gap.

The reasoning assumes ZK proofs are the only line of defense in a system. Alex draws a parallel to aviation, nuclear controls, and medical devices.

Each of those is complex, mission-critical, and capable of catastrophic failure. None were abandoned for that reason—they operate through redundancy and containment, not the absence of risk.

In a post on X, @gluk64 framed it as a broader pattern. Any complex, mission-critical technology that can fail catastrophically would fail Canton’s test.

Canton founders claim ZK proofs are too risky for institutional finance. They have been making this argument to buyers and regulators, publicly and behind closed doors. It deserves a public answer.

Let's see if the argument holds — and if Canton's infrastructure passes its own…

— ALEX | ZK (@gluk64) March 27, 2026

The hidden assumption doing all the work is that no backup system exists. That assumption, not the technology itself, is what creates systemic danger.

Canton’s own architecture illustrates this point. Its privacy model relies solely on trusted operators to segregate data between participants. There is no cryptographic verification layer in place.

If operator keys are compromised, the manipulated state propagates silently across opaque chains with nothing to catch it.

Prividium’s Layered Defense and the Open Standards Question Prividium builds its model on three independent layers of defense. Institutional partners operate nodes within their own regulated environments.

Zero-knowledge proofs then add a cryptographic verification layer above operational security. As proof systems mature, multiple independent provers can verify the same computation. A flaw in one implementation then gets caught by another.

Containment is built into the architecture by design. Each Prividium instance is a separate chain operated by a single institution.

Inter-chain interactions go through accounting mechanisms enforced independently by participating institutions or on-chain. Even a combined attack on internal IT and a ZKP bug stays confined to that one chain.

The open standards question adds another layer to the comparison. ZKsync’s move toward full EVM equivalence reflects the principle that deviating from open standards widens the attack surface.

Ethereum’s infrastructure has faced more than a decade of adversarial testing with hundreds of billions at stake. That process built stronger audit standards, formal verification tools, and hardened design patterns.

Canton’s maturity concerns about ZK proofs apply equally to DAML, its proprietary smart contract language. DAML operates within a closed ecosystem with far fewer developers and security researchers watching.

Every vulnerability cycle Ethereum worked through still lies ahead for DAML. The architecture with the longest track record under the harshest conditions carries the least risk.

TLDR: World Foundation raised $65M through OTC sales of WLD tokens to four counterparties in one week. $25M worth of tokens are locked for six months to reduce short-term selling pressure risks. Funds will support Orb manufacturing, research, and expansion of the Worldcoin ecosystem. WLD trades near $0.27, aligning closely with the average OTC transaction price disclosed. WLD OTC funding event raised $65 million through private token transactions, as the organization looks to strengthen its operational capacity and ecosystem development strategy.

OTC Transactions and Funding Structure World Foundation confirmed it raised $65 million through over-the-counter sales of WLD tokens. The transactions were executed via its subsidiary, World Assets, Ltd., within a single week.

🚨WORLD FOUNDATION COMPLETES $65M WLD OTC SALES

World Foundation closed a series of OTC sales totaling $65M with four counterparties over the past week, with the first settlement on March 20, 2026.

Tokens were sold at ~$0.2719 each, with $25M locked for 6 months. pic.twitter.com/kDbai49Vi7

— Coin Bureau (@coinbureau) March 28, 2026

Four counterparties participated in the OTC deals, purchasing tokens at an average price of approximately $0.2719.

The first settlement occurred on March 20, marking the start of the funding process. The transfers were conducted through a secure multisignature wallet system.

OTC transactions allow large token movements without affecting open market prices. This method helps reduce volatility during sizable allocations.

Market participants often view such deals as indicators of institutional engagement and structured capital inflows.

The organization shared updates about the transactions through social media channels. These disclosures outlined the funding process and confirmed the counterparties’ participation. The communication approach aimed to maintain transparency with the broader crypto community.

Additionally, blockchain analytics reports referenced earlier token transfers involving WLD. These observations align with ongoing activity surrounding supply distribution. The latest funding round adds to a series of structured token movements in recent weeks.

Capital Allocation and Ecosystem Expansion A portion of the funds includes $25 million in tokens placed under a six-month lockup period. This restriction limits immediate resale activity and helps manage potential market pressure. Lockups are commonly used in token sales to support price stability.

The raised capital is designated for several operational priorities. These include research and development, infrastructure growth, and manufacturing of biometric Orb devices. The initiative supports the broader ecosystem linked to Worldcoin (WLD).

World Foundation stated that the funding will also contribute to expanding network adoption. This includes scaling user access and improving system capabilities. The organization continues to focus on building its identity verification infrastructure.

The ecosystem tied to Worldcoin has shown steady growth in recent months. Nearly 18 million users have been verified globally through its system. The World App wallet serves around 39 million users across more than 160 countries.

Infrastructure deployment has also increased, with hundreds of Orb devices now active. Recent data recorded over 60,000 new accounts created within a week. Verification activity also remained consistent during the same period.

The funding secured through World Foundation WLD OTC Sales aligns with ongoing development goals. It supports operational continuity while enabling further expansion of the network’s global footprint.

Why Trust CoinGape

CoinGape has covered the cryptocurrency industry since 2017, aiming to provide informative insights to our readers. Our journal analysts bring years of experience in market analysis and blockchain technology to ensure factual accuracy and balanced reporting. By following our Editorial Policy, our writers verify every source, fact-check each story, rely on reputable sources, and attribute quotes and media correctly. We also follow a rigorous Review Methodology when evaluating exchanges and tools. From emerging blockchain projects and coin launches to industry events and technical developments, we cover all facets of the digital asset space with unwavering commitment to timely, relevant information.

Cardano founder Charles Hoskinson criticized Ripple CEO Brad Garlinghouse during a a weekly crypto rollup video over support of the CLARITY Act, arguing the proposal could reshape crypto regulation. He accused Garlinghouse of backing a framework that could classify most projects as securities. 

Charles Hoskinson CLARITY Act Criticism  In a weekly rollup youtube video, Charles Hoskinson framed his criticism around the structure of the CLARITY Act and its potential enforcement impact. According to him, the bill could treat most digital assets as securities by default. 

He argued this approach resembles actions previously taken by Gary Gensler against crypto firms. This criticism comes as the CLARITY Act faces delays due to stablecoin yield disagreements. Hoskinson said the proposed framework gets support from Brad Garlinghouse since it could benefit Ripple and XRP. 

He claimed this would reduce competition across the broader ecosystem. As a result, he described the bill as harmful to innovation and unfair to smaller projects. He further outlined multiple enforcement risks tied to the CLARITY Act. 

According to Hoskinson, regulators could apply several legal pathways to classify new projects as securities. He warned this could limit entry for developers and startups. Notably, he also pointed to the removal of protections for DeFi developers.

Liability Concerns and Developer Protections Hoskinson raised concerns about developer liability under the CLARITY Act which faces uncertainty as crypto czar David Sacks stepped down. He said the bill could expose developers to unlimited legal responsibility. This, he argued, would apply even when developers have no direct control over how their code is used. 

He referenced cases involving open-source developers, including those linked to Tornado Cash. According to him, the absence of safeguards could discourage software development in crypto. He added that such liability would create uncertainty across the industry. 

Meanwhile, Hoskinson criticized the broader reaction to his stance. He said discussions around the CLARITY Act have become difficult due to strong community responses. He argued that debates often move away from the substance of arguments toward personal reactions.

Following Coinbase’s opposition of the stablecoin yield compromise, the odds of the CLARITY Act being signed into law in 2026 have dropped. As per Polymarket data, the odds have dropped to 52%, which is a 13% drop from levels above 60% earlier in the week.

Source: Polymarket

XRP Community Response  Charles Hoskinson also addressed backlash from the XRP community. He said critics have accused him of attacking XRP despite his past support. However, he stated that he has been publicly defending Ripple during its legal battle with regulators.

Hoskinson referenced earlier statements where he opposed regulatory action against Ripple. He said those positions remain documented and accessible. Despite this, he claimed some community members now question his intentions.

CP Markets Crypto WatchlistThe crypto market faces a wholesome decline in price this week, with Bitcoin dropping to 2 weeks low near $66000. Altcoins like Etherem looses 7% in a week below $2000 USD, Solana, BNB, XRP, Shib, Doge, Pepe, and many of the previous performers have been dull. Although there is positive institutional participation, the uncertain geopolitical situation has increased market greed. 

Coinpedia Markets’ analysis for next week forecasts a neutral-to-bullish week. Bitcoin will trade in a range of $66000 and $72,000, and altcoins that performed positive growth may repeat the cycle.

Here is our list of altcoin watchlist for next week. 

Bittensor (TAO) Target:  $414.60Bittensor(TAO)] is among the star performers, with a monthly growth of nearly 80%, reaching from a low of $171 to 375.  

Currently trading at $320.62 with -2.29% growth, TAO/USDT in a 4-hour frame shows firm bullish growth. RSI at 48 is neutral buying pressure, but the altcoin price is trading above the Ichimoku cloud, showing a buyer’s confidence. 

Bittensor (TAO) Target: $414.60
Moving in an upward channel, the price may retract to a buying opportunity dip between $280 to $305. In the same scenario, followed by correction, the TAO coin is expected to trade in the $380 to $415 zone in the next 2 weeks. 

In case of trend invalidation, Bittensor coin prints a strong support at $300 phsycoligal level. 

Siren ( SIREN)  Target: $4 The newly launched AI-memecoin on BSC, SIREN, has been on the top gainers’ charts for the last week. At press time, SIREN coin is trading at $1.66, with 24h growth if 101% and monthly growth 337%. It is also to note the the previous two trading days, it fell neatly 62% in days, falling to around $0.875. 

Despite all the Scrutiny and warnings about a major concentration of circulating supply being held by the team, SIREN coin is a dramatic and clear result of FOMO mixed with ongoing uncertainty. 

SIREN/USDT is also seen with balanced long/short derivatives, which can amplify the price further near the horizontal resistance $1.7 range. Holding strong above this level could trigger the rally to the next resistance near $2.06.

Siren ( SIREN) Target: $4
In a bearish scenario, a break below $1.50, SIREN could retest the support at $1.20.

Midnight (NIGHT) Target: $0.072015The Cardano-based coin Midnight (NIGHT) reacted bullish again after the Monument Bank of the UK announced its plan to tokenize ADA and NIGHT tokens. Further, today, the rally was supported by the Australian exchange CoinSpot listing yesterday. 

NIGHT coin at the time of writing is trading at $0.05164, up 12.4% in 24 hours and moved 18.67% in in one month. Launched in early March, Midnight coin has gained its place in the Top 50 coins by marketcap of $744.4m USD. 

NIGHT/USDT 4-hour chart shows the coins shows the altcoin is gaining back the momentum. Average Directional Index ( ADX) is at 26 and upward direction, indicating that buyers have entered since 26 March. The MACD line is above the signal; there is a sharp shift in momentum for further gains. 

Midnight (NIGHT) Target : $0.072015
The Support for NIGHT now sits at $0.045 and $0.0423, and a resistance pain point at $0.5517, breaking beyond will push the altcoin to the $0.07 zone. 

Other Coins on the List are Pudgy Penguins ( $PENGU)

Now: $0.006546Target: $0.0077River ( $RIVER)

Now: $14.58 Target: $22WikiCat ( $WKC) 

Now: $0.0000001104Target: $0.00000018504Qubic ( $QUBIC) 

Now: $0.0000009989Target: $0.00000166719Osaka Protocol ( $OSAK)

Now: $0.00000004137Target: $0.000000070414Dusk ( $DUSK)

Now: $0.1104Target: $0.2110Hachiko ( $HACHI)

Now: $0.000000005016Target: $0.0000000157491The market is significantly affected by the ongoing war situation, and Bitcoin is falling due to the uncertainty, which is making altcoins fall too. But the above coins are the ones that have not been majorly impacted by the trend. 

Trust with CoinPedia:CoinPedia has been delivering accurate and timely cryptocurrency and blockchain updates since 2017. All content is created by our expert panel of analysts and journalists, following strict Editorial Guidelines based on E-E-A-T (Experience, Expertise, Authoritativeness, Trustworthiness). Every article is fact-checked against reputable sources to ensure accuracy, transparency, and reliability. Our review policy guarantees unbiased evaluations when recommending exchanges, platforms, or tools. We strive to provide timely updates about everything crypto & blockchain, right from startups to industry majors.

Investment Disclaimer:All opinions and insights shared represent the author's own views on current market conditions. Please do your own research before making investment decisions. Neither the writer nor the publication assumes responsibility for your financial choices.

Sponsored and Advertisements:Sponsored content and affiliate links may appear on our site. Advertisements are marked clearly, and our editorial content remains entirely independent from our ad partners.

20h05 ▪ 4 min read ▪ by Luc Jose A.

Summarize this article with:

Bitcoin approaches a decisive threshold. Around 60,000 dollars, the market equilibrium weakens. The latest data suggest that breaking this level could extend the bearish phase far beyond expectations. Between degraded technical signals, persistent selling pressure, and an uncertain macroeconomic environment, recovery prospects are fading. The scenario of a longer cycle now dominates analyses.

In brief Bitcoin approaches a critical threshold around 60,000 dollars, likely to redefine market dynamics. Data shows a marked drop since the peak, accompanied by indicators still far from a true bottom. A more severe scenario considers a drop towards 40,000 – 45,000 dollars, with consequences for cycle duration. Projections suggest a return to highs potentially postponed until 2027. The $60,000 threshold under close watch Bitcoin has erased all of its recent gains, recording a 24.6 % decline over the quarter, while marking a retreat of about 48 % since its peak of 126,000 dollars reached in October 2025.

Ecoinometrics data reveals a direct relationship between the depth of corrections and the length of the recovery. Thus, “each additional 10 % drop adds about 80 days to the recovery phase”, a key factor for anticipating the course of the cycle.

Several market signals reinforce this reading :

Stabilization around 60,000 dollars would still allow a return to the highs in about 300 days, consistent with historical cycles ; The BCMI index stands at 0.27, far from the capitulation threshold around 0.15 ; On-chain data shows persistent selling pressure, with a whale delta of -22.13 ; Liquidity, on both spot and derivatives markets, shows signs of contraction. These factors reflect a still fragile market, where conditions for a true bottom do not seem met.

An extreme scenario pushing back Bitcoin recovery Beyond the 60,000 dollars threshold, projections become much darker. Historical models mention the possibility of a retreat to a zone between 40,000 and 45,000 dollars, corresponding to a total drop of 64% to 68% from the peak.

In this case, market dynamics would shift scale. The study indicates that such a scenario would extend the recovery duration to about 440 days, delaying a return to highs until after the second quarter of 2027.

This scenario takes place in a less favorable macroeconomic environment. Expectations of rate cuts have been revised downward, while some models now incorporate a probability of further hikes by 2027.

This shift limits risk appetite and restricts capital flow towards cryptos. The ongoing cycle could thus deviate from usual dynamics, often characterized by fast rebounds after the halving, favoring a slower and extended market adjustment phase.

In this context, the hypothesis of a prolonged cycle redefines investor expectations. Between still fragile technical signals and persistent macroeconomic constraints, Bitcoin could evolve within a zone of lasting uncertainty. The history of past cycles offers benchmarks, but current dynamics remind us that each market phase has its own rules, and that the next peak might depend as much on monetary policies as on the structural adoption of the asset.

Maximize your Cointribune experience with our "Read to Earn" program! For every article you read, earn points and access exclusive rewards. Sign up now and start earning benefits.

Join the program

A

A

Lien copié

Luc Jose A.

Diplômé de Sciences Po Toulouse et titulaire d'une certification consultant blockchain délivrée par Alyra, j'ai rejoint l'aventure Cointribune en 2019. Convaincu du potentiel de la blockchain pour transformer de nombreux secteurs de l'économie, j'ai pris l'engagement de sensibiliser et d'informer le grand public sur cet écosystème en constante évolution. Mon objectif est de permettre à chacun de mieux comprendre la blockchain et de saisir les opportunités qu'elle offre. Je m'efforce chaque jour de fournir une analyse objective de l'actualité, de décrypter les tendances du marché, de relayer les dernières innovations technologiques et de mettre en perspective les enjeux économiques et sociétaux de cette révolution en marche.

DISCLAIMER

The views, thoughts, and opinions expressed in this article belong solely to the author, and should not be taken as investment advice. Do your own research before taking any investment decisions.

Trusted Editorial content, reviewed by leading industry experts and seasoned editors. Ad Disclosure

Morgan Stanley’s 16,000 financial advisors manage $6.2 trillion in client assets. That number has been sitting in the background of a major filing — and it explains a lot about why the bank set its proposed Bitcoin ETF fee where it did.

A Fee Built For Advisors, Not Just Investors The bank filed an updated S-1 registration statement with the SEC on Friday, setting the fee for its proposed Morgan Stanley Bitcoin Trust at 0.14%.

If approved, that would make it the lowest fee of any spot Bitcoin ETF currently trading in the US market. Bloomberg ETF analyst Eric Balchunas said the fee was set with advisors in mind — at that price point, no one on the firm’s sales floor would feel awkward recommending the product to clients.

Morgan Stanley disclosed the 0.14% fee in its latest S-1 filing on Friday. That is a practical calculation. Advisors who push high-fee products into client portfolios face questions. At 0.14%, those questions go away.

BlackRock’s iShares Bitcoin Trust charges 0.25%. The Grayscale Bitcoin Mini Trust sits at 0.15%. Morgan Stanley is going in one basis point below both of its nearest rivals.

Bloomberg ETF analyst James Seyffart called it a big move and said an early April launch is likely, pending regulatory approval.

WOW. We have the fee on Morgan Stanley’s spot bitcoin ETF $MSBT. Will charge just 0.14% !!! Big move here. They are not messing around. Likely to launch in early April. https://t.co/R0iA3wMB5N

— James Seyffart (@JSeyff) March 27, 2026

Image: Kitco First Bank To Issue A Spot Bitcoin ETF Approval would put Morgan Stanley in a category of one. No major bank has yet issued a spot Bitcoin ETF in the US. That distinction, combined with a rock-bottom fee and a distribution network of thousands of advisors, gives the product a strong early position if it clears the SEC.

Bitcoin is now trading at $66,180. Chart: TradingView The bank named Coinbase and Bank of New York Mellon as custodians for the fund. Those are two of the most established names in digital asset custody, and the pairing signals that Morgan Stanley is building this to last — not testing the waters.

Rivals will now face a decision. The $83 billion spot ETF market has operated with fees clustered around 0.20% to 0.25%. A new entrant coming in below all of them puts pressure on existing providers to respond or accept the risk of losing assets over time.

More Than Just Bitcoin The Bitcoin ETF is one piece of a larger push. In January, Morgan Stanley also filed for a Solana ETF and a staked Ether ETF. Weeks later, it applied for a national trust banking charter that would allow it to custody digital assets, carry out trades, and offer staking services directly to clients.

Featured image from Unsplash, chart from TradingView

Editorial Process for bitcoinist is centered on delivering thoroughly researched, accurate, and unbiased content. We uphold strict sourcing standards, and each page undergoes diligent review by our team of top technology experts and seasoned editors. This process ensures the integrity, relevance, and value of our content for our readers.

Sign Up for Our Newsletter! For updates and exclusive offers enter your email.

Christian, a journalist and editor with leadership roles in Philippine and Canadian media, is fueled by his love for writing and cryptocurrency. Off-screen, he's a cook and cinephile who's constantly intrigued by the size of the universe.

Trusted Editorial content, reviewed by leading industry experts and seasoned editors. Ad Disclosure

Shiba Inu is facing renewed selling pressure as SHIB’s exchange netflows indicate that more holders are moving their coins to exchanges. This comes as the U.S.-Iran war continues to spark bearish sentiment for the foremost meme coin and the broader crypto market. 

Shiba Inu’s Exchange Netflows Turn Positive As SHIB Faces Sell-off CryptoQuant data shows that Shiba Inu’s exchange netflows have turned positive, with a difference of around 39 billion SHIB. This indicates that the meme coin is facing increased selling pressure, as exchange inflows are currently well ahead of outflows. This development also coincides with the SHIB price decline, with the meme coin down 5% in the last week. 

Source: Chart from CryptoQuant Santiment data also shows the massive gap between Shiba Inu’s exchange inflows and outflows, further confirming the sell pressure that the meme coin is currently facing. As of March 28, Shiba Inu’s exchange inflow is 69.2 billion, while the outflow is 30.74 billion. Another negative is that SHIB whales are currently sitting on the sidelines and choosing not to accumulate the meme coin. 

Related Reading: Can Shiba Inu Still Make A Comeback? Lack Of Update On Shibarium L3 Proves To Be A Problem

Further data from Santiment shows that daily Shiba Inu whale transactions are currently in the single digits and effectively non-existent, down from an average of over 100 transactions recorded in December 2025. However, a positive for SHIB is that its supply on exchanges hasn’t climbed to the highs seen in September 2025. The current supply on exchanges is 138 trillion, still below the September high of 143 trillion. 

Meanwhile, although Shiba Inu whales are choosing not to accumulate and remain on the sidelines, the supply held by these cohorts remains steady, indicating there has yet to be a massive sell-off. These whales currently hold 774.25 trillion SHIB, above the recent low of 690.91 trillion SHIB.  

Shibarium Transactions Waver Shibariumscan data shows that daily transactions on the layer-2 network remain volatile, with brief surges followed by new lows. The daily Shibarium transactions notably climbed from 3,430 on March 25 to a one-month high of around 10,940 on March 26. However, daily transactions quickly fell to a low of 1,230 on March 27. 

Meanwhile, it is worth noting that a significant number of these Shibarium transactions over the last few days have been zero-dollar contract call transactions, signaling a lack of utility for the layer-2 network at the moment. Shiba Inu burns have also crashed as a result of the decline in daily transactions on Shibarium. Shibburn data shows that Shiba Inu burns in the last 24 hours have crashed by 66%, dropping to 2.7 million SHIB. 

At the time of writing, the Shiba Inu price is trading at around $0.000005737, down over 3%, according to data from CoinMarketCap.

SHIB trading at $0.000005 on the 1D chart | Source: SHIBUSDT on Tradingview.com Featured image from Adobe Stock, chart from Tradingview.com

Editorial Process for bitcoinist is centered on delivering thoroughly researched, accurate, and unbiased content. We uphold strict sourcing standards, and each page undergoes diligent review by our team of top technology experts and seasoned editors. This process ensures the integrity, relevance, and value of our content for our readers.

Sign Up for Our Newsletter! For updates and exclusive offers enter your email.

Scott Matherson is a leading crypto writer at Bitcoinist, who possesses a sharp analytical mind and a deep understanding of the digital currency landscape. Scott has earned a reputation for delivering thought-provoking and well-researched articles that resonate with both newcomers and seasoned crypto enthusiasts. Outside of his writing, Scott is passionate about promoting crypto literacy and often works to educate the public on the potential of blockchain.

Ethena’s [ENA] price now appears to be aligning with its weakening financial performance. Over the past 24 hours, the asset has recorded a double-digit decline, dropping to $0.089 at press time.

While the numbers reflect mounting pressure, a broader evaluation of market conditions is necessary to determine whether this decline marks the start of a deeper correction or a temporary adjustment.

Ethena’s momentum weakens across key metrics On-chain data shows that ENA has underperformed across multiple fronts since the start of Q1 2026, particularly when compared to its performance in the previous two quarters.

A key area of concern is revenue efficiency. Gross Protocol Revenue fell to $65.06 million, down from $96.15 million in Q4 2025, representing a 32% decline. The drop becomes even more pronounced when compared to Q3 2025.

This contraction points to weaker minting activity and reduced staking rewards, both of which suggest declining on-chain participation.

Source: DeFiLlama In a market that has remained relatively stable compared to the October–December 2025 cycle, this underperformance raises concerns about weakening user demand rather than external pressure.

Liquidity conditions reinforce this trend. Total Value Locked (TVL), a core indicator of protocol health and user commitment, has continued to decline steadily.

Since the start of March 2026, TVL has fallen by approximately $130 million, bringing it to around $6.66 billion at the time of writing. Within the last 24 hours alone, roughly $16 million has been unstaked, signaling sustained capital exit from the protocol.

Can profit alone sustain user interest? Despite the broader slowdown, Ethena has recorded a slight improvement in gross profitability.

In Q1 2026, the protocol has generated $614,190 in gross profit, compared to $463,200 in Q4 2025. While this reflects a marginal increase, it does little to offset the sharp decline from earlier performance levels.

For context, Q3 2025 saw $10.18 million in gross profit, roughly 16.5 times higher than current figures. This gap highlights a structural decline in earning potential, even as short-term profitability shows minor improvement.

The implication is clear, as modest profit growth alone may not be sufficient to retain users, especially in a competitive DeFi environment where capital quickly rotates toward higher-yield opportunities.

User activity data supports this view. According to Artemis, Daily Active Users have dropped to around 1,200, the lowest level recorded since December.

Spot demand offers a counter-signal Despite weakening fundamentals and declining liquidity, spot market activity presents a more resilient picture. Exchange netflow data indicates that buying pressure has increased recently. Over the past 24 hours, net inflows into spot positions reached approximately $303,000.

More notably, this is not an isolated event. Over the past three days, cumulative purchases have climbed to around $3.41 million, suggesting consistent accumulation.

Source: CoinGlass Such a sustained demand indicates that investors continue to absorb sell-side pressure, even as capital exits the protocol layer.

If this accumulation trend holds, it could limit further downside and support price stabilization. However, without a recovery in core fundamentals, particularly user activity and revenue generation, any upside may remain constrained within a narrow range.

Final Summary Ethena’s protocol performance deteriorated in Q1 2026, even as broader market conditions remained relatively stable. Spot investors continue to accumulate, despite rising liquidity outflows and declining TVL.

Central banks are adopting a firmer tone once more, and financial markets are responding with notable intensity. According to CoinShares’ (OTCQX: CNSRF) Market Update released on March 27, 2026, expectations for interest-rate hikes have surged sharply across the United States, eurozone, and United Kingdom. This repricing stems primarily from renewed geopolitical strains—particularly the ongoing Iran conflict—and fleeting shifts in investor sentiment.

Just weeks ago, traders were betting on rate cuts by the Federal Reserve as early as June; today, the probability of a hike sits around 15 percent, amplified by month-end options expirations that have added to the pressure on risk assets.

Yet CoinShares cautions that this hawkish pivot may be overstated.

The broader economic landscape tells a more complex story.

Inflation remains overwhelmingly supply-driven, fueled above all by energy costs, rather than by overheating demand or entrenched wage pressures that monetary tightening is designed to combat.

At the same time, economic growth is visibly softening.

Policymakers, still scarred by their delayed response to inflation in 2022, appear biased toward preemptive action.

However, tightening policy under current conditions—where domestic demand is already subdued—could unnecessarily squeeze activity without addressing the root causes of price increases.

The bar for further rate hikes, the report argues, should be set considerably higher than current market pricing suggests.Bitcoin has displayed notable staying power amid the turbulence.

Although it has partially realigned with traditional macro forces in recent sessions, its performance stands out.

Since the escalation of the Iran conflict, bitcoin has gained 6.4 percent, while European equities have fallen 9.1 percent and gold has dropped a surprising 14.4 percent.

This relative strength underscores cryptocurrency’s resilience even as broader risk sentiment sours.

Beyond the immediate macro debate, CoinShares highlights encouraging regulatory progress.

The CLARITY Act for stablecoins is advancing in the U.S. Senate, with the latest draft proving less punitive than many anticipated.

While exchanges will be barred from offering deposit-like yields on stablecoin holdings, rewards linked to actual transaction volume, loyalty programs, and promotional activities remain explicitly allowed.

This balanced approach, coupled with a one-year timeline for agencies to refine definitions, represents a constructive step for the digital-asset industry.

The bitcoin mining sector, meanwhile, faces structural upheaval.

Hash prices have slid to post-halving lows of roughly $28–$30 per PH/s per day, pushing cash costs per bitcoin to around $80,000 in late 2025 and rendering 15–20 percent of the global fleet unprofitable.

In response, major operators are aggressively pivoting toward artificial intelligence and high-performance computing infrastructure.

Over $70 billion in cumulative AI/HPC contracts have already been announced, with some firms on track to generate up to 70 percent of revenues from data-center services by the end of 2026.

This shift has dramatically altered the sector’s risk profile, ballooning debt levels and creating a clear valuation divide: miners with secured HPC deals now command premium multiples, while pure-play bitcoin miners trade at steep discounts.

In summary, CoinShares views the latest hawkish repricing as more reflexive than fundamental.

While short-term volatility persists, the underlying macro dynamics—supply-side inflation and weakening growth—suggest central banks may ultimately exercise greater restraint. For bitcoin and the broader crypto ecosystem, this nuanced environment continues to highlight opportunities amid the noise.

Ripple Labs Chief Executive Officer Brad Garlinghouse offered a detailed assessment of his company’s trajectory following a string of strategic purchases. He described the firm’s progress as steady, pointing to strengthened operational capabilities and broadened market presence that have emerged directly from those integrations.

According to Garlinghouse‘s remarks in a recent interview, the acquisitions have enabled Ripple Labs to accelerate innovation in blockchain-based payment solutions and enhance its competitive positioning within the digital asset sector.

This growth phase reflects a deliberate shift toward consolidation, allowing the organization to absorb specialized talent, technology, and customer networks that complement its core offerings in cross-border transactions.

Garlinghouse emphasized that the company has experienced measurable advancements in efficiency and scale since completing the deals.

He noted that internal synergies have unlocked new revenue streams and improved service delivery for institutional clients worldwide.

The executive portrayed these developments as evidence of Ripple Labs’ commitment to long-term sustainability, even amid fluctuating market conditions.

By weaving together complementary assets through the acquisitions, the firm has reportedly fortified its infrastructure against volatility while positioning itself for sustained leadership in fintech innovation.

Shifting to the broader policy landscape, Garlinghouse struck a note of caution regarding future regulatory developments.

He warned that additional legislation aimed at the cryptocurrency industry is likely to require more time than many observers initially expected.

In the interview with Fox Business, the CEO suggested that lawmakers and regulators continue to grapple with complex technical and economic considerations, which could extend the timeline for meaningful new frameworks.

This measured perspective underscores the challenges of balancing innovation with investor protection and financial stability in an evolving sector.

Garlinghouse’s remarks arrive at a pivotal moment for the crypto industry, where regulatory clarity remains a top priority for market participants.

He acknowledged that while some progress has been made in recent years, the path toward comprehensive rulesets is inherently deliberate.

The executive advocated for thoughtful, well-informed policymaking that avoids hasty measures capable of stifling technological advancement.

His comments reflect a pragmatic stance shared by many industry leaders who seek predictability to support responsible growth.

Overall, Garlinghouse’s comments combined optimism about Ripple Labs’ internal momentum with realism about external hurdles.

The acquisitions appear to have provided a solid foundation for expansion, yet the CEO’s tempered view on legislation highlights the importance of patience in navigating governmental processes.

As the digital finance space matures, stakeholders will be watching closely to see how such corporate strategies intersect with regulatory timelines. For Ripple Labs, the key takeaway was obvious: strategic investments are yielding results today, but broader industry evolution will demand endurance and collaboration in the months and years ahead.

XRP price bounced roughly 3% from its March 27 low of $1.31, reclaiming the $1.35 area. However, the move may be building a bear flag rather than the start of a sustained recovery, and the broader market conditions are not helping.

Since peaking at $1.60 on March 17, XRP has already corrected 18%. The intraday bounce looks constructive on the surface, but the chart, derivatives, and on-chain data all point in the same direction.

The 12-hour chart shows XRP trading inside a bear flag pattern. The pole formed during the 18% decline from $1.60 to $1.31 between March 17 and March 27. The current 3% bounce is shaping the flag portion, a rising channel that typically resolves with another leg down matching the pole’s size.

If the lower trendline of the flag breaks, a similar 18% measured move could be triggered from the breakdown point. That would take the XRP price toward the $1.08 zone (highlighted later in the price section).

The Relative Strength Index (RSI), a momentum oscillator, adds another layer of concern. Between February 6 and March 28, on the 12-hour chart, the price is forming a lower high while the RSI is forming a higher high.

That is a hidden bearish divergence, which typically points to a continuation of the existing downtrend rather than a reversal.

RSI Hidden Bearish Divergence: TradingViewWant more token insights like this? Sign up for Editor Harsh Notariya’s Daily Crypto Newsletter here.

The divergence has not yet been confirmed. Confirmation requires the next 12-hour candle to close below $1.35. If instead the price clears $1.35 and sustains above it, the structure delays.

Full invalidation sits above $1.60, the pole’s peak. If the broader market continues to weaken, this setup could confirm quickly.

However, even without the RSI, the derivatives and spot data suggest the bounce is standing on thin ground.

Open Interest Rises, but Hodlers Are Reducing PositionsSince the bounce began, XRP open interest has risen from $737.72 million to $759.21 million, a 2.9% increase. At the same time, the funding rate has become less negative, moving from -0.011% to -0.003%. That combination means more long positions are being opened into the bounce.

XRP Open Interest and Funding Rate: SantimentRising open interest during a bounce inside a bear flag is typically a warning rather than a bullish confirmation. It means some leveraged traders are betting on bounce continuation, but if the pattern breaks down, those new longs become liquidation fuel.

The spot market offers no counterbalance. The Hodler net position change, a Glassnode metric tracking accumulation by longer-term wallets (155 days or more), held steady between March 19 and March 25 at approximately 238 million XRP.

Since March 25, that balance has dropped to 229.78 million XRP, a reduction of roughly 8.25 million tokens or 3.47%.

XRP Hodler Net Position Change: GlassnodeConviction holders are quietly reducing exposure right before the XRP price bounces. When derivatives lean long, and spot holders lean out, the setup favors the bears.

If the RSI-led hidden bearish divergence confirms and the price corrects, the spot support needed to absorb the selling simply is not there. It remains to be seen whether spot buyers also come in, as the recent longs did. If that happens, some spot support can help stem the possible drop.

XRP Price Forecast and the $1.35 TestThe XRP price needs a clean 12-hour close above $1.35 to delay the bearish setup. Above that, $1.37 and $1.40 become the next resistance levels. However, based on the bear flag structure and the divergence forming, any move under $1.35 that holds would begin the confirmation process.

If the flag breaks and the $1.31-$1.32 neckline zone gives way, the measured move of roughly 18% activates from the breakdown point. That targets the $1.08 zone, which would then represent the lowest level for XRP since early February 2026.

On the upside, only a move above $1.60 would fully invalidate the bearish structure and end the lower-high sequence that has defined XRP’s 2026 trading playbook.

XRP Price Analysis: TradingViewFor now, the $1.35 reclaim separates a delayed bearish setup from an 18% breakdown toward $1.08.

Measured in ETH rather than dollars, Lido's total value locked fell from 9.63 million ETH to 8.81 million ETH.

Lido, the largest liquid staking protocol on Ethereum, closed 2025 with total revenue of $40.5 million, down 23% from $52.4 million the year before, according to an execution report published by the Lido Foundation.

The DAO is now reviewing an automated LDO token buyback mechanism, with the deployment targeted for Q2 2026, as part of a broader effort to align the governance token’s value with the protocol’s financial performance.

A Difficult Year for Staking Revenue In the report, Lido noted that its main source of income, staking fee revenue, fell from $48.5 million to $37.4 million. In addition, there was a drop in execution layer rewards as a result of the ongoing network scaling on Ethereum, as well as a decrease in consensus layer rewards that was built into the issuance curve, with both weighing on the protocol’s income.

Meanwhile, gross staking rewards across the entire protocol fell 18% in dollar terms, from approximately $1.03 billion to $846.7 million. There was also a decline in Lido’s share of the staked ETH market, with its holdings going from more than 28% of all staked ETH in 2024 to just over 24% in December 2025.

In ETH terms, total value locked fell from 9.63 million ETH to 8.81 million ETH, a drop of 8.5%. The report attributes the share loss to capital rotating toward exchange staking, institutional low-risk staking, and liquid restaking platforms that used their own protocol tokens to subsidize returns.

However, Ethereum’s staking environment has since improved, even taking the network to new activity record highs in 2026.

Expansion and Buyback Plans Market data from CoinGecko shows the native LDO trading at $0.27 as of March 27, down 7.3% over the past seven days. The token has hovered near its recent lows, with a 24-hour range between $0.275 and $0.290, and remains close to its all-time low of $0.2714 recorded on March 8, 2026.

You may also like: Ethereum Tipping Point: Whales Selling Amid Fresh Accumulation (Analyst) Analyst Warns BTC Dominance Break Will Dictate Whether Alts Explode or Collapse Bitcoin Leads $1.06B Surge in Digital Assets Amid Geopolitical Turmoil Meanwhile, the protocol is developing a potential LDO buyback plan that would operate under the Network Economic Support Tokenomics (NEST) framework. Once live, the offering will enable users to buy LDO from the open market using protocol-generated yields and place the tokens into an LDO/wstETH liquidity position controlled by the platform.

As part of this, Lido shared that it has already completed the development of a manual module that would allow governance-controlled token swaps ahead of a planned technical validation scheduled for Q2 release. The firm added that any buyback mechanism only activates once a genuine treasury surplus exists.

Last year, the firm launched Lido Earn, a platform meant for high-yield stakers, that now holds more than 77,000 ETH in TVL. It came after WisdomTree launched the first stETH liquid staking ETP in Europe. The product also includes integrations with BitGo, Hex Trust, Komainu, and Crypto Finance AG that provide clients with more custody and staking options.

Tags:

Luisa Crawford Mar 28, 2026 16:31

LDO shows bullish momentum with 8.81% daily gains and RSI at neutral 52.61. Technical analysis suggests potential targets of $0.35-0.40 in coming weeks if resistance at $0.33 breaks.

LDO Price Prediction Summary • Short-term target (1 week): $0.33-0.35 • Medium-term forecast (1 month): $0.35-0.40 range
• Bullish breakout level: $0.33 • Critical support: $0.28

What Crypto Analysts Are Saying About Lido DAO While specific analyst predictions for March 2026 are limited, recent forecasts provide context for our LDO price prediction. According to earlier analysis from CoinCodex in December 2025, Lido DAO was predicted to reach $0.651700 by early January 2026. Blockchain.News had suggested potential upside of 16-23% to the $0.66-$0.70 range within their forecasting period.

However, current market conditions show LDO trading significantly below those projections at $0.31, indicating either delayed momentum or revised market dynamics. On-chain data from major platforms suggests the liquid staking sector continues to evolve with Ethereum's ongoing developments.

LDO Technical Analysis Breakdown Current technical indicators present a mixed but cautiously optimistic picture for this Lido DAO forecast. LDO is trading at $0.31 with impressive 24-hour gains of 8.81%, suggesting renewed buying interest after recent consolidation.

The RSI reading of 52.61 positions LDO in neutral territory, providing room for upward movement without immediate overbought concerns. This neutral RSI supports our LDO price prediction for continued recovery potential.

Moving averages tell an interesting story with short-term averages (SMA 7 and 20 both at $0.30) sitting below the current price, indicating recent bullish momentum. However, the SMA 200 at $0.66 highlights how far LDO has declined from previous highs, suggesting significant resistance ahead.

The Bollinger Band position at 0.79 shows LDO trading in the upper portion of its recent range, approaching the upper band at $0.32. The MACD histogram at 0.0000 indicates weakening bearish momentum, potentially setting up for a bullish crossover.

Lido DAO Price Targets: Bull vs Bear Case Bullish Scenario In the optimistic case for our LDO price prediction, immediate resistance at $0.32 represents the first hurdle. A clean break above this level could target the strong resistance at $0.33, which aligns with our short-term forecast.

If bullish momentum sustains and breaks $0.33 convincingly, the next logical targets sit in the $0.35-0.40 range over the coming month. This Lido DAO forecast assumes continued sector rotation into liquid staking tokens and broader crypto market stability.

Key technical confirmation would come from RSI pushing above 60 and MACD generating a positive crossover, combined with sustained volume above the current $6.4 million daily average.

Bearish Scenario The bear case centers on LDO failing to hold current levels, with immediate support at $0.29 being tested. A breakdown below this level could see price action retreat to the strong support at $0.28, matching the lower Bollinger Band.

More concerning would be a break below $0.28, which could signal a retest of recent lows and invalidate our bullish LDO price prediction. The significant gap between current prices and the SMA 200 at $0.66 illustrates the considerable ground lost and potential for further weakness if market sentiment deteriorates.

Should You Buy LDO? Entry Strategy Based on current technical positioning, conservative entry points for LDO would be on any pullback toward the $0.30 pivot point or stronger support at $0.29. This approach allows buyers to enter near technical support levels while maintaining manageable risk.

More aggressive traders might consider current levels around $0.31, given the positive daily momentum and neutral RSI reading. However, this strategy requires tight stop-losses below $0.28 to protect against breakdown scenarios.

For this Lido DAO forecast to play out successfully, position sizing should account for the token's daily ATR of $0.02, indicating moderate volatility that could work for or against positions quickly.

Conclusion Our LDO price prediction suggests cautious optimism with targets of $0.33-0.35 over the next week and $0.35-0.40 within a month, assuming technical resistance breaks hold. The combination of recent 8.81% gains, neutral RSI positioning, and weakening bearish MACD momentum supports this outlook.

However, investors should note that LDO remains significantly below previous analyst projections and faces substantial overhead resistance. This Lido DAO forecast carries moderate confidence given current technical setup, but requires careful risk management given the token's recent volatility.

Disclaimer: This analysis is for informational purposes only and should not be considered financial advice. Cryptocurrency investments carry significant risk, and past performance does not guarantee future results. Always conduct your own research and consider your risk tolerance before investing.

Image source: Shutterstock

ldo price analysis ldo price prediction

Bitcoin advocates are questioning a newly drafted bipartisan tax bill, arguing the legislation aggressively penalizes miners with prohibitive tax structures.

The draft legislation, known as the PARITY Act, was circulated by US Reps. Max Miller and Steven Horsford. The bill aims to overhaul the Internal Revenue Code to clarify the taxation of digital assets in the United States.

Why Crypto Leaders Against the PARITY Act?However, the proposal has instead ignited dispute within the broader cryptocurrency industry.

At the center of the controversy is the bill’s divergent treatment of different blockchain consensus mechanisms. The draft intends to classify earnings from cryptocurrency production as gross income, calculated at fair market value upon receipt.

Crucially, the legislation allows participants in proof-of-stake networks, such as Ethereum and Solana, to defer these taxes until the asset is eventually sold.

Bitcoin, conversely, operates on a proof-of-work system that requires substantial upfront capital for specialized hardware and substantial ongoing energy costs. Under the current PARITY Act draft, Bitcoin miners are excluded from this tax deferral.

Conner Brown, managing director of the Bitcoin Policy Institute, stated that the draft retains double taxation on Bitcoin mining while providing targeted relief to staking operations. Brown argued the proposed legislation arbitrarily picks economic winners and losers.

“[The bill] creates a two-tier tax regime, offering deferral to stakers while leaving miners stuck with the same phantom income problem that both parties acknowledged needed fixing,” the Bitcoin Policy Institute argued.

Furthermore, the draft legislation would ease tax treatment for the use of certain GENIUS Act-defined payment stablecoins in everyday payments.

The Bitcoin Policy Institute said the provision would make it harder for consumers to use Bitcoin for small retail purchases. It said those transactions could still trigger capital gains reporting requirements, adding a tax burden to everyday spending.

“[The draft] provides a $200 de minimis exemption for payment stablecoins but not bitcoin, which alone represents 60% of the market cap of all digital assets. This means that a person who buys a cup of coffee with bitcoin still faces a capital gains calculation. A de minimis exemption for everyday bitcoin transactions is necessary for the digital asset’s maturation as it grows into a global medium of exchange. Any legislation serious about promoting parity must include it,” the think tank added.

Industry Experts Highlight Room For ImprovementsWhile Bitcoin purists push back against the exemptions, broader industry lobbying groups are attempting to leverage the draft as a starting point for wider legislative reform.

Cody Carbone, CEO of The Digital Chamber, welcomed the PARITY Act legislation but emphasized the need for significant revisions to prevent the industry from moving overseas.

“We’re excited to see a bipartisan digital asset tax discussion draft. We have been prioritizing tax clarity for this entire Congress – hence the excitement the draft was out so we can begin truly advocating in a public forum,” he stated.

While expressing excitement that a public discussion draft is finally available, he noted that the current iteration requires major improvements.

Against that backdrop, Carbone outlined several core revisions his organization is demanding. These include taxing both staking and mining rewards only upon sale or disposition, establishing a broader de minimis exemption beyond stablecoins, and shielding basic technical actions, such as moving crypto between personal wallets, from taxation.

He also called for simplified tax forms to avoid duplicative reporting and clearer guidelines for lending and donating digital assets.

Here's how bitcoin, Ethereum and other networks are preparing for the looming quantum threatAcross many of the most well-known ecosystems like Bitcoin, Ethereum, and Solana, responses are diverging along familiar lines: what to do on social consensus and technical iteration, and community members are split between caution and acceleration. Mar 28, 2026, 4:00 p.m.

As quantum computing edges closer to practical reality, the crypto industry is beginning to confront a question it has long deferred: what happens if the cryptography underpinning trillions of dollars in digital assets no longer holds?

The answers, so far, are anything but uniform.

Across many of the most well-known ecosystems like Bitcoin, Ethereum, and Solana, responses are diverging along familiar lines: what to do on social consensus and technical iteration, and community members are split between caution and acceleration.

Quantum computing is a fundamentally different approach to computation that uses the principles of quantum mechanics rather than classical physics. Instead of traditional bits that are either 0 or 1, quantum computers use “qubits,” which can exist in multiple states at once, a property known as superposition, allowing them to process many possibilities simultaneously.

Combined with another feature called entanglement, this enables quantum machines to solve certain complex problems far more efficiently than classical computers, particularly tasks like factoring large numbers that underpin modern encryption.

How threatening is quantum computing? Consider this: Quantum computers can solve extremely complex problems within seconds, whereas 'Supercomputers,' the most powerful computing machines available today, would take thousands of years for the same problems, according to IBM.

And that's why the threats to cryptographic networks stemming from quantum computing are concerning. And even Google, developer of Willow, a quantum supercomputer, is setting a 2029 deadline to migrate its authentication services to post-quantum cryptography, citing progress in the technology.

Fierce Bitcoin debateNowhere is the tension more visible than in Bitcoin.

While the risks posed by quantum computing have been understood since the network’s earliest days, the debate began meaningfully a few years back, when developers started more seriously discussing post-quantum signature schemes and the long-term implications of exposed public keys.

The threat became very real recently, when some Wall Street analysts, such as Jefferies, said investors should drop bitcoin from their portfolios altogether because of the looming risk to the network. While that has struck a nerve with some investors, others, including Cathie Wood's Ark Invest, came to defend Bitcoin, saying quantum computing is a long-term risk but a risk nonetheless.

Ark's quantum timeline (Ark)For years, these discussions remained largely academic, but as Taproot activated in 2021 and quantum research continued to advance, attention shifted toward practical questions — how to migrate funds, how to handle vulnerable coins, and whether upgrades could be introduced without breaking Bitcoin’s core guarantees. More recently, that abstract concern has started to crystallize into concrete proposals.

Developers are now focusing on a basic issue: some older bitcoin could be easier to break if quantum computers improve. One proposal, called BIP360, is about helping users move those coins into safer addresses over time, rather than forcing a sudden network-wide change. At the same time, more experimental ideas are being discussed. One, known as “Hourglass,” would gradually limit the use of vulnerable coins unless they’re moved, giving owners time to act while reducing the risk of theft. While some estimates say millions of bitcoin — including about 1 million linked to Satoshi — could be exposed, not everyone sees this as a major threat. Some argue the market could absorb it, and that the bigger risk is making drastic changes that go against Bitcoin’s core principles.

That tension underscores a deeper challenge: any solution must navigate Bitcoin’s core ethos of immutability and minimal intervention. As a result, Bitcoin’s quantum strategy is emerging not as a single roadmap, but as a spectrum of proposals whose fate will depend less on technical feasibility than on whether the community can reach consensus without compromising the principles that define the network.

Read more: Bitcoin’s quantum threat is real, but far from an existential crisis, Galaxy says

Ethereum and CoinbaseIf Bitcoin is still debating 'whether' to act, Ethereum and its surrounding ecosystem have largely moved on to 'how.'

Throughout 2025, the Ethereum Foundation quietly ramped up efforts by creating a dedicated quantum research team and elevating post-quantum security from a theoretical concern to a strategic priority. The shift reflects a growing sense among core developers that timelines may be compressing, and that preparation cannot wait for definitive breakthroughs in quantum hardware.

The Ethereum roadmap is not about a single upgrade, but a phased transition. Research has focused on integrating post-quantum signature schemes into future iterations of the protocol, alongside broader architectural changes like LeanVM, which aim to make the system more adaptable to new cryptographic primitives. Rather than forcing an abrupt migration, the goal is to build optionality: allowing developers and users to adopt quantum-resistant tools incrementally, without breaking compatibility with existing infrastructure.

That same philosophy is visible with some of the biggest companies in crypto. Coinbase, one of the largest U.S.-based crypto exchanges, recently established an independent advisory board composed of cryptographers, academics and quantum computing experts. The group is tasked with assessing risks, guiding implementation strategies and ensuring that defenses evolve alongside the threat landscape. The move signals that quantum preparedness is no longer confined to protocol developers — it is becoming a business and operational concern as well.

Ethereum layer-2 networks are also beginning to map their own paths. Optimism, a major Ethereum scaling solution, has outlined early thinking around post-quantum upgrades. While still at a conceptual stage, the effort underscores a broader trend: rather than waiting for a single, ecosystem-wide solution, different layers of the stack are beginning to experiment in parallel.

Taken together, Ethereum’s approach has recognized that quantum risk is real, but that the transition must be carefully managed to avoid introducing new vulnerabilities.

Solana's quiet shiftSolana, by contrast, has taken a quieter and more experimental route.

In December 2025, developers in its orbit began introducing early designs for quantum-resistant tooling, including a concept known as the “Winternitz Vault.” The idea is to give users the option to store assets in smart contract-based vaults secured by hash-based, one-time signatures—an approach widely considered more resistant to quantum attacks.

Unlike a protocol-level overhaul, these vaults function as an additional security layer. Users who are concerned about long-term quantum risk can opt in, while the broader network continues to operate unchanged. For now, Project Eleven will lead the charge to advance post-quantum security for Solana.

The initial reaction from the Solana community has been broadly positive, with developers and users welcoming the experimentation. Still, quantum computing has not emerged as a sustained flashpoint in ecosystem discourse, and discussion remains relatively subdued compared to the more urgent debates playing out elsewhere.

This divergence in approaches highlights a deeper truth about the crypto industry: there is no consensus yet on how urgent the quantum threat really is. Some argue that practical attacks may still be years away, or that they are overblown. Others warn that the transition to quantum-resistant systems could take just as long, meaning preparation must begin well in advance.

What is clear is that the issue is no longer hypothetical. The creation of dedicated research teams, advisory boards and experimental tools marks a shift from abstract concern to active planning. Even in Bitcoin, where change is hardest, the mere fact that freezing coins is being discussed signals how far the conversation has moved.

For now, the industry’s response resembles an early stress test rather than a coordinated defense.

Read more: Quantum threat gets real: Ethereum Foundation prioritizes security with leanVM and PQ signatures

More For You

As stablecoins evolve into core financial infrastructure, North America leads. This report maps the regulation, market shifts, and players driving adoption.

Why it matters:

Stablecoins are entering their third phase of evolution - the institutionalization era - becoming increasingly embedded into core financial infrastructure. As institutions prioritize transparency and compliance, regulated issuers like USDC, RLUSD, and PYUSD are steadily gaining share with RLUSD surpassing $1B in market cap within its first year. North America, leading in regulatory frameworks and institutional distribution, is at the center of it all.

More For You

A draft blog post left in an unsecured data cache revealed a new model tier called Capybara that Anthropic says is more capable than anything it has built, with the company flagging "unprecedented" cybersecurity risks.

What to know:

A leaked draft blog post revealed that Anthropic is testing a new AI model, Claude Mythos, which it internally describes as by far its most powerful system to date.The model, part of a new "Capybara" tier, reportedly delivers dramatically better performance than Claude Opus 4.6 on coding, academic reasoning...

Rising geopolitical tensions, resurgent rate-hike fears and deep-pocketed institutional buying are converging into a pivotal moment for XRP.

Market Sentiment:

Bullish Bearish Neutral

Published: March 28, 2026 │ 3:55 PM GMT

Created by Gabor Kovacs from DailyCoin

An XRP-focused mainstream crypto commentator is tying the latest Middle East troop buildup, shifting Federal Reserve expectations and fresh pension-fund data into a single warning for XRP holders: geopolitical escalation and higher-for-longer rates could trigger another wave of crypto pain before the next bull cycle.

In a recent video, Levi Rietveld from Crypto Crusaders argues that renewed U.S. military moves around Iran, combined with surging oil prices, are already feeding into markets and may delay or even reverse the rate-cut narrative that underpinned much of the previous crypto rally.

Troop Deployments, Oil & Return Of Rate Hike TalkDrawing on a Wall Street Journal report, the analyst highlights that the U.S. is considering deploying up to 10,000 additional troops to the Middle East, on top of 10,000 already sent, plus 5,000 Marines and paratroopers from the 82nd Airborne.

Sponsored

The proposed force would include infantry and armored vehicles, a posture the host describes as “designed for a ground invasion.”

He links this to the earlier phase of the current U.S.–Iran–Israel conflict, when an American aircraft carrier entered the region shortly before missile strikes on Iranian targets.

In Levi’s view, this pattern suggests that more direct confrontation is “not a coincidence” and is already pressuring risk assets. “The more escalations there are, the more downwards pressure there is on the price of all digital assets,” he says, noting that oil prices are pushing higher at the same time.

The video leans heavily on one macro data-point: the stated 48% probability of a Fed rate hike by January 2027, a scenario he says was viewed as “pretty much impossible” only a few months ago.

Elevated oil, Levi argues, is keeping inflation sticky and “solidifying the fact that we’re not going to be getting rate declines” until energy markets normalize, potentially well into 2026.

Pension Funds Buy The Dip While XRP Tests SupportAgainst that backdrop, Levi Rietveld points to what he sees as a contradictory signal: large U.S. pension funds turning into net buyers of equities after a sharp draw-down.

Citing Goldman Sachs estimates, he says pensions are expected to purchase about $13.8 billion of U.S. stocks into quarter-end, versus a long-term average of roughly $1.8 billion in monthly selling since the 2000s.

He frames these institutions as historically adept at stepping in near local bottoms, highlighting their aggressive buying during the 2020 COVID crash and around the tariff war period in the previous Trump administration.

Recent market turmoil, he says, has erased over $1 trillion from U.S. equities and hundreds of billions from crypto, creating what pension managers appear to view as a discount window.

For XRP specifically, Levi Rietveld notes the token is trading around $1.34 and has just touched a key support line on his charts, while still “showing some signs of short-term weakness.”

Taken together with the pension-flow data and the scale of liquidations seen across exchanges, he believes the market is “getting very close to the bottom,” even if the precise low is not yet in.

Levi also warns that a renewed rate-hike cycle similar to 2022–2023 could once again prove “catastrophic” for overleveraged crypto players, reviving contagion risks despite a stronger overall market structure.

The takeaway is stark but nuanced: ongoing war risk and higher oil prices may extend macro headwinds for digital assets, yet large institutional buyers are already repositioning for the next two to three years. In that tension between near-term downside and long-term accumulation, XRP and broader crypto could face more volatility before any sustained recovery.

Discover DailyCoin’s popular crypto news today:
Crypto’s Next Wave: Are Mid and Small Caps Set to Outshine Bitcoin?
Will Cardano Repeat History? Last $0.25 Test Delivered a 200% Rally

People Also Ask:How could a new Fed rate hike affect XRP and other cryptos?

Higher rates generally weaken risk assets by raising funding costs and making safer yields more attractive. The host expects renewed hikes to pressure crypto prices and potentially trigger further liquidations.

Why do pension funds buying stocks matter for crypto?

The commentator sees large pension flows into equities after big draw-downs as a signal that long-horizon institutions view current valuations as attractive. He infers this may also mark a favorable accumulation zone for major crypto assets.

Is the analyst calling a definitive bottom for XRP?

No. He stresses that while XRP is near support and broader markets look discounted, “we might not have found the actual bottom yet,” though he believes the market is closer to it than most realize.

What role does the Iran conflict play in this outlook?

In his framework, escalation raises oil prices, which fuels inflation and keeps the Fed hawkish. That macro setup is, in his view, the core risk factor weighing on crypto over the next year.

DailyCoin's Vibe Check: Which way are you leaning towards after reading this article?

Market Sentiment

100% Bearish

This article is for information purposes only and should not be considered trading or investment advice. Nothing herein shall be construed as financial, legal, or tax advice. Trading forex, cryptocurrencies, and CFDs pose a considerable risk of loss.

The latest figures from defillama.com show the fiat-pegged token economy pulled back over the past week, shedding $1.04 billion since March 21. Seven of the top ten stablecoins posted net outflows during that stretch.

USDC Sees $1.37B in Outflows as Stablecoin Market Shrinks As of this weekend, defillama.com stats show tether ( USDT) continues to dominate the sector with a market capitalization of $184.068 billion, even after a modest seven-day dip of -0.03%, or just over $56 million in outflows. USDT currently accounts for 58.42% of the stablecoin sector’s total valuation, which stands at $315.072 billion after the $1.04 billion loss.

Circle’s USDC follows with a market cap of $77.723 billion, though it logged a steeper weekly decline of -1.73%. That places USDC’s outflows at roughly $1.372 billion since March 21. In third position, sky dollar (USDS) carries a market cap of $8.146 billion, down 1.18% over the past week, while Ethena’s USDe sits fourth at $5.904 billion after a modest 0.32% weekly decline.

Rounding out the top five, Sky’s DAI stands at a $4.555 billion market cap as of Saturday, posting a 0.32% weekly decline in line with USDe’s performance. World Liberty Financial’s USD1 stablecoin shed -0.54% this past week and now stands with a market cap of $4.404 billion. PYUSD ranks seventh with a market capitalization of $3.87 billion, recording a sharper weekly drop of 4.80%.

Positions eight through ten moved against the broader trend, each posting net inflows over the same stretch. Blackrock’s BUIDL takes the eighth spot with a $2.699 billion market cap and a 6.15% weekly gain. Just behind it, Circle’s USYC ranks ninth at $2.609 billion, leading this cohort with a 7.26% increase over the past week.

Rounding out the top ten, Global Dollar’s USDG holds a $1.692 billion market cap, posting a 1.23% weekly gain. The $1.04 billion in outflows coincides with a broader pullback across the crypto economy this week, wiping out a large share of early March’s gains. Still, the week’s stablecoin data points to selective contraction rather than systemic stress, with capital rotating instead of exiting entirely.

The largest issuers absorbed the bulk of redemptions, while smaller entrants captured incremental inflows. If this pattern holds, the stablecoin stack may be entering a phase defined less by expansion and more by redistribution, where positioning and utility quietly shape the next leg.

FAQ 🔎 What caused the $1.04 billion drop in the stablecoin market?
The decline was driven by net redemptions across seven of the top ten stablecoins, led primarily by USDC outflows. Why is USDC seeing larger outflows than USDT?
USDC recorded heavier redemptions as capital shifted away from it while USDT maintained dominant market share. Which stablecoins gained inflows this week?
Blackrock’s BUIDL, Circle’s USYC, and Global Dollar’s USDG posted net inflows despite the broader market decline. What does this stablecoin shift mean for the crypto market?
The data suggests capital rotation within stablecoins rather than full exits, signaling repositioning instead of broad market stress.

17h10 ▪ 6 min read ▪ by Evans S.

Summarize this article with:

Elizabeth Warren puts Bitmain back under pressure in Washington. This time, the issue is neither the price of Bitcoin nor speculation. It concerns a much more sensitive point: American national security and the place of a Chinese manufacturer at the heart of the global mining infrastructure.

In brief Elizabeth Warren places Bitmain at the center of a sensitive file in the United States. Bitcoin hardware becomes a national security issue. The links between Bitmain and American Bitcoin make the case even more political. Warren brings Bitcoin hardware into the political arena Elizabeth Warren now targets Bitmain head-on. In a letter addressed to Commerce Secretary Howard Lutnick, the senator requests documents, internal exchanges and details on how the administration handles risks related to the Chinese manufacturer. The signal is clear: the case is no longer just technical, it becomes political.

This offensive is based on a federal investigation already revealed in November 2025. According to Bloomberg, the operation, called “Operation Red Sunset,” sought to determine whether certain Bitmain ASIC machines could be remotely exploited for espionage or disruption of the American power grid. The exact status of this investigation remains unclear, which further fuels suspicion.

The most important thing here is elsewhere. When a senior senator demands accountability regarding the hardware that powers part of the global Bitcoin, it means that the industry is no longer seen as a simple technological market. It enters the classic logic of industrial rivalry between Washington and Beijing.

Bitmain is not a secondary company in the Bitcoin ecosystem Bitmain is not a peripheral player. The group occupies a central position in the market for ASIC machines, those specialized devices that secure the Bitcoin network through mining. According to the Cambridge Digital Mining Industry Report, the sector leader alone captures about 82% of the market, while the three main manufacturers together exceed 99%.

It is this weight that makes the case explosive. When such a dominant supplier is targeted by security suspicions, the issue goes far beyond Bitmain itself. It touches the hardware dependency of part of the global mining, including in the United States, on a very concentrated supply chain. Bitcoin is decentralized at the protocol level, but its physical industry remains much more concentrated.

Bitmain understands this well. The company announced in 2025 its plan for the first American factory, with initial production expected in early 2026 and a ramp-up later in the year. On paper, this choice might have seemed purely industrial. In reality, it also looked like an attempt to anchor locally in an already tense geopolitical climate.

The case becomes even more sensitive with the Trump network The most delicate point of this case remains the link between Bitmain and American Bitcoin, the mining company supported by Eric Trump and Donald Trump Jr. Reuters reported in 2025 the launch of this structure with Hut 8. Bloomberg later indicated that American Bitcoin had signed a contract to purchase 16,000 Bitmain machines for 314 million dollars.

Warren’s letter therefore does not stop at the technological risk. She also requests details on possible communications between Bitmain, the Trump family, and Commerce Department officials. In other words, she poses a second, even more political question: can a sensitive foreign company benefit from special treatment because of its connections to the presidential entourage?

This mix of Bitcoin, national security, China, and closeness to the Trump family gives the case a much broader scope than a simple regulatory dispute. Even without public prosecution at this stage, the message sent to the market is clear: in the United States, owning or selling mining machines is no longer just a matter of energy performance or profitability. It is now also a matter of sovereignty.

What this case really says about industrial Bitcoin The Bitmain episode reveals a contradiction that often returns in the Bitcoin industry. The network was designed to reduce political dependencies. Yet, its real infrastructure still depends on manufacturers, ports, chips, customs, and state arbitrations. Protocol neutrality does not remove the vulnerability of the industrial chain.

This is probably what makes the case more important than it seems. Warren is not attacking Bitcoin as such. She shines a light on the fact that behind the narrative of an open network remain concentration points capable of becoming national security issues. This is a distinction that many industry players prefer to avoid.

For the market, the next steps will matter. If Washington toughens its stance on Bitmain, the whole US mining sector might have to rethink its suppliers, its costs, and its expansion strategy. And if nothing happens quickly, the mere suspicion will nonetheless continue to weigh. In industrial politics, doubt alone is sometimes enough to change the game.

Maximize your Cointribune experience with our "Read to Earn" program! For every article you read, earn points and access exclusive rewards. Sign up now and start earning benefits.

Join the program

A

A

Lien copié

Evans S.

Fascinated by Bitcoin since 2017, Evariste has continuously researched the subject. While his initial interest was in trading, he now actively seeks to understand all advances centered on cryptocurrencies. As an editor, he strives to consistently deliver high-quality work that reflects the state of the sector as a whole.

DISCLAIMER

The views, thoughts, and opinions expressed in this article belong solely to the author, and should not be taken as investment advice. Do your own research before taking any investment decisions.

President Trump intensifies the U.S. push to dominate bitcoin and crypto markets, declaring Bitcoin “very powerful” as policy shifts, regulatory clarity, and rising adoption accelerate digital assets’ role in national economic strategy.

Trump Signals Aggressive Push Toward Crypto Leadership A stronger federal push toward digital assets emerged as U.S. President Donald Trump addressed the Future Investment Initiative Summit in Miami on March 27. The remarks emphasized positioning the United States at the center of bitcoin adoption and crypto market expansion.

“My administration has also worked tirelessly to ensure that America remains at the bleeding edge of crypto revolution. We’re really doing great. And if we’re not going to do it, then China is going to take it over. They want to do it,” Trump said. Setting the tone for market ambition, he declared:

“We’re going to be the undisputed crypto capital and Bitcoin superpower of the world. Bitcoin’s very powerful. It’s all becoming powerful.”

“So many people, now, they want to pay you in crypto. They want to pay you in bitcoin, and we have to be at the top of it in all of these—call it an industry,” Trump stressed.

Linking that outlook to policy groundwork, he pointed to stablecoin legislation, stating: “Last year I signed the landmark Genius Act into law, creating a clear and simple framework for dollar-backed stablecoins.” Emphasizing the significance, he added that “this was a historic achievement,” and stressed he will “not allow Democrats and their big bank donors” to deter progress. Addressing political dynamics, he noted, “Although they’ve had a lot of support for crypto … the Democrats have been very strong on crypto. They want to see it too, which is shocking if you want to know the truth.”

Regulatory Clarity and Growth Agenda Drive Momentum Regulatory developments tied to the address included joint interpretations issued March 17, 2026, by the U.S. Securities and Exchange Commission (SEC) and Commodity Futures Trading Commission (CFTC), which categorized many digital assets, including bitcoin, ether, and XRP, as digital commodities. The move redirected oversight away from enforcement-led actions and aligned with the GENIUS Act’s framework for dollar-backed stablecoins, establishing clearer conditions for issuance and compliance.

Outlining a broader regulatory philosophy, he said:

“But we don’t want any pointless regulations or needless restrictions. We want to have free enterprise, open. America became the world financial capital because we were the strongest and the freest nation on earth. And the Trump administration’s going to keep it that way. We’re very open.”

Beyond digital assets, the address also highlighted artificial intelligence and advanced manufacturing as parallel priorities within a wider economic agenda. The administration tied these sectors to a target of attracting more than $2.7 trillion in technology investment, positioning innovation-led growth alongside expanding financial market infrastructure.

He concluded by emphasizing accessibility in governance. “And I tell people, if you have problems, call me. Call me. And some of them are amazed. I actually take their call and get their problem solved,” Trump claimed.

FAQ 🧭 What did Trump say about bitcoin’s importance?
He described Bitcoin as very powerful and central to future financial systems. How is the U.S. positioning itself in crypto markets?
The administration is aiming to make the U.S. the global hub for crypto adoption and innovation. What role does regulation play in this strategy?
Clearer rules are intended to support growth while reducing uncertainty for investors and companies. Why is crypto tied to broader U.S. economic policy?
It is being integrated into a wider push for technological leadership and investment expansion.